Health Condition 1: D509- Iron deficiency anemia, unspecified
Conditions
Interventions
Intervention1: Intravenous iron sucrose: Intravenous iron sucrose 200 mg (2 ampoules of 100 mg) in 100 ml 0.9% NS over 15-30 minutes on alternate days until the total dose will be administered (not to
Sponsors
Dr Kalpana kumari
Eligibility
Inclusion criteria
Inclusion criteria: Antenatal women of second and third trimester of pregnancy with moderate anemia with hemoglobin 7-9.9gm/dl and who are willing to participate in study
Exclusion criteria
Exclusion criteria: Non iron deficiency anemia Bleeding disorders or coagulopathy History of blood transfusion during antenatal period Hypersensitivity reaction to any iron preparation Previous surgery of intestinal resection Co morbid conditions like cardiovascular disease chronic liver or renal disease Medical disorders like tuberculosis, hepatitis B/C or HIV infection
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Outcomes will be measured on basis of changes in hemoglobin and iron indices like Serum Iron Serum Ferritin TIBC Transferrin saturation and safety and acceptability of intravenous iron sucrose vs ferric carboxymaltose will be determinedTimepoint: Baseline on Day 0 and then on day 30 | — |
Secondary
| Measure | Time frame |
|---|---|
| nilTimepoint: nil | — |
Countries
India
Contacts
Public ContactDR SONAM CHOUDHARY
University of medical sciences Saifai
Outcome results
None listed